Clinical trials
Observational Polycythemia Vera trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2020 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 4 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Icahn School of Medicine at Mount Sinai | 4 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| City of Hope Medical Center | 1 |
| FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS | 1 |
| Incyte Corporation | 1 |
| MPN Research Foundation | 1 |
| National Institutes of Health Clinical Center (CC) | 1 |
| Novartis Pharmaceuticals | 1 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1 |
| University of Utah | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Polycythemia Vera | 15 |
| Thrombocythemia, Essential | 12 |
| Myeloproliferative Disorders | 11 |
| Primary Myelofibrosis | 11 |
| Blast Crisis | 6 |
| Burkitt Lymphoma | 5 |
| Immunoblastic Lymphadenopathy | 5 |
| Immunoglobulin Light-chain Amyloidosis | 5 |
| Intraocular Lymphoma | 5 |
| Leukemia, Biphenotypic, Acute | 5 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.